IGF DES 100 mcg x 5 Vials – Thaiger Pharma

Description

Thaiger Pharma IGF DES 100 mcg is a specialized research peptide formulated with Insulin-Like Growth Factor-1 DES (IGF-1 DES 1-3), a truncated variant of the native IGF-1 molecule engineered to exhibit enhanced receptor accessibility and rapid biological activity. Owing to its distinctive molecular structure, IGF DES has become an important tool in growth factor research, enabling scientists to investigate localized cellular responses, regenerative signaling, and the molecular mechanisms that drive tissue adaptation.

Unlike longer-acting IGF analogues, IGF DES is characterized by its reduced interaction with IGF Binding Proteins (IGFBPs), allowing researchers to focus on direct receptor-mediated signaling. This unique property has positioned the peptide at the forefront of studies involving cellular proliferation, skeletal muscle biology, satellite cell activation, and regenerative physiology, making it an essential component of advanced peptide research.

Each package contains 5 lyophilized vials, with 100 mcg of IGF DES per vial, providing a precise and consistent formulation for laboratory investigations. Manufactured by Thaiger Pharma, every batch undergoes strict quality control to ensure outstanding purity, stability, and reproducibility for professional scientific applications.

Key Features

• Premium IGF DES (IGF-1 DES 1-3) research peptide
• 100 mcg of high-purity peptide per vial
• 5 lyophilized vials per pack
• Short-acting Insulin-Like Growth Factor analogue
• Reduced affinity for IGF Binding Proteins (IGFBPs)
• High-purity laboratory-grade formulation
• Extensively researched in regenerative biology and growth factor signaling
• Suitable for investigations involving cellular proliferation, satellite cell biology, tissue regeneration, and molecular signaling
• Manufactured under rigorous quality assurance standards
• Intended exclusively for laboratory and scientific research applications

How It Works

IGF DES (IGF-1 DES 1-3) is a modified form of Insulin-Like Growth Factor-1 created by removing the first three amino acids of the native peptide. This structural modification significantly reduces its binding to IGF Binding Proteins, enabling researchers to study more direct interactions with IGF-1 receptors and the downstream signaling pathways responsible for cellular growth and regeneration.

In laboratory environments, IGF DES is widely utilized to investigate localized growth factor activity, activation of intracellular pathways such as PI3K/Akt and MAPK/ERK, satellite cell behavior, and the molecular events involved in tissue repair and cellular differentiation. Its rapid biological profile makes it particularly valuable for research examining short-duration growth factor signaling and targeted regenerative responses.

This formulation is intended exclusively for laboratory and scientific research and is not intended for human consumption.

Contents

Active Ingredient: Insulin-Like Growth Factor-1 DES (IGF DES 1-3) – 100 mcg

Packaging: 5 Lyophilized Vials